Brief: Biocartis Expands Collaboration Agreement With Astrazeneca

Biocartis NV

04/05/2021 06:06

May 4 (Reuters) - Biocartis Group NV  BCART.BR :
    * BIOCARTIS ANNOUNCES NEW COLLABORATION WITH ASTRAZENECA TO EXPAND
AVAILABILITY OF
IDYLLA™ EGFR BIOMARKER TESTING AMONG PATIENTS WITH LUNG CANCER
    * ANNOUNCES TO HAVE SIGNED A NEW AGREEMENT WITH ASTRAZENECA AIMED AT
PROVIDING
ACCESS TO RAPID AND EASY-TO-USE IDYLLA™ EGFR TESTING PRODUCTS AT SELECTED
HOSPITAL SITES IN BIOCARTIS' EUROPEAN AND GLOBAL DISTRIBUTOR MARKETS
    * NEW PROJECT EXPANDS EXISTING MASTER COLLABORATION AGREEMENT BETWEEN
BIOCARTIS
AND ASTRAZENECA, WHICH WAS ESTABLISHED TO PROMOTE AND BOLSTER ACCESS TO FASTER
MOLECULAR DIAGNOSTIC BIOMARKER RESULTS

Source text for Eikon:  ID:nNDLBY4SS 
Further company coverage:  BCART.BR 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))